Company Overview - Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with key products including various injections and capsules, many of which are unique in the market and covered by national health insurance [2]. Financial Performance - For Q1 2025, the company reported revenue of 100 million yuan, a year-on-year decrease of 0.46%, and a net loss of approximately 11.9 million yuan, representing a significant year-on-year decline of 960.04%. The gross profit margin stood at 66.62% [3]. Market Position - As of August 18, the company's stock closed at 5.73 yuan, down 1.21%, with a rolling price-to-earnings (PE) ratio of 35.62 times. The total market capitalization is 5.041 billion yuan. In comparison, the average PE ratio for the chemical pharmaceutical industry is 66.18 times, with a median of 36.46 times, placing the company at the 89th position in the industry ranking [1][3]. Shareholder Information - As of March 31, 2025, the number of shareholders for the company was 34,311, a decrease of 6,228 from the previous count. The average market value of shares held per shareholder is approximately 352,800 yuan, with an average holding of 27,600 shares [1].
ST景峰收盘下跌1.21%，滚动市盈率35.62倍，总市值50.41亿元
Sou Hu Cai Jing·2025-08-18 08:35